Intakes of long-chain omega-3 (n−3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study by Li, Jingjing et al.
Intakes of long-chain omega-3 (n23) PUFAs and fish in relation
to incidence of asthma among American young adults: the
CARDIA study1–3
Jingjing Li, Pengcheng Xun, Daisy Zamora, Akshay Sood, Kiang Liu, Martha Daviglus, Carlos Iribarren, David Jacobs Jr,
James M Shikany, and Ka He
ABSTRACT
Background: Although long-chain v-3 (n23) PUFAs (LCv3PUFAs)
have been linked to the prevention of some inflammatory disorders,
little is known about the association between these fatty acids and
incidence of asthma.
Objective: The objective was to prospectively investigate the asso-
ciation between LCv3PUFAs and fish intake and incidence of
asthma among American young adults.
Design: A 20-y follow-up longitudinal analysis was conducted in
a biracial cohort of 4162 Americans, aged 18–30 y, with a history
of asthma at baseline in 1985. Diet was assessed by a validated
interviewer-administered quantitative food-frequency questionnaire
at the examinations in 1985, 1992, and 2005. Incident self-reported
asthma was defined as having a physician diagnosis of asthma and/
or the use of asthma medications between 1985 and 2005.
Results: During the 20-y follow-up, 446 incident cases of asthma
were identified. LCv3PUFA intake was significantly inversely
associated with incidence of asthma after adjustment for sociodemo-
graphic, major lifestyle, and dietary confounders. The multivariable-
adjusted HR for the highest quintile of LCv3PUFA intake as
compared with the lowest quintile was 0.46 (95% CI: 0.33, 0.64;
P-trend , 0.01). However, a higher frequency of nonfried fish con-
sumption was not significantly associated with the risk of asthma.
DHA showed a greater inverse association than did EPA. The associ-
ation between LCv3PUFAs and incident asthma was not appreciably
modified by sex, race, BMI, smoking status, or atopic status.
Conclusion: This study showed that intakes of LCv3PUFAs are
inversely longitudinally associated with the incidence of asthma
in American young adults. Am J Clin Nutr 2013;97:181–6.
INTRODUCTION
Asthma is characterized by chronic inflammation of the air-
ways that results in narrowing of the bronchial tubes (1). One in
12 Americans of all ages suffers from this health disorder, and an
increase of 12.3% occurred during the past decade according to
the CDC (2). The increased prevalence of asthma highlights the
need for devising effective preventative strategies. Long-chain
v-3 (n23) PUFAs (LCv3PUFAs)4, including EPA (20:5v-3),
docosapentaenoic acid (22:5v-3), and DHA (22:6v-3), are
abundant in fish and have been shown to be antiinflammatory (3,
4). Because asthma is an inflammatory process, it has been
hypothesized that a high intake of LCv3PUFAs may have
beneficial effects on asthma development (5).
Data relating LCv3PUFA or fish intake to the risk of
asthma are sparse in humans (6). Most previous studies on
LCv3PUFA or fish intake and asthma were cross-sectional (7–
12). Three prospective studies, including 2 long-term studies
(13, 14) and 1 short-term study (15), have evaluated the in-
cidence of asthma in adults but failed to find a clear association
with LCv3PUFA intake. These 2 studies were conducted in
well-educated middle-aged women (34–68 y at baseline) (13)
or older men (.65 y at baseline), a substantial proportion
(92%) of whom were smokers (14). Some misclassification of
asthma and chronic obstructive pulmonary disease may have
occurred in smokers (16). Because these 2 diseases share some
common features, they may be difficult to distinguish in older
patients clinically (17). Therefore, we used data from the
Coronary Artery Risk Development in Young Adults (CARDIA)
study to examine the association between intakes of LCv3PUFAs
and fish and the 20-y incidence of asthma among young American
adults.
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SUBJECTS AND METHODS
Study population
The CARDIA study is a prospective multicenter cohort study
designed to investigate cardiovascular disease risk factors in
African American and white men and women (18). The CARDIA
cohort comprised 5115 Americans aged 18–30 y who were re-
cruited from 4 US cities in 1985–1986; the recruitment was
balanced within each center on sex and race. Six follow-up
examinations were conducted, in 1987, 1990, 1992, 1995, 2000,
and 2005. Approximately 70% of the participants in the original
cohort returned for the sixth follow-up visit in 2005.
In the current analyses, we excluded participants with prev-
alent asthma at baseline (n = 474). We also excluded participants
who lacked information for defining asthma in any follow-up
(n = 176). In addition, we excluded participants who 1) had
missing data on LCv3PUFA and/or total energy intake (n = 4),
2) reported implausible total energy intake in dietary assess-
ments (,800 or .8000 kcal/d for men and ,600 or .6000
kcal/d for women; n = 38), or 3) had missing information on key
covariates, including smoking status (n = 28), alcohol con-
sumption (n = 15), and physical activity (n = 1). We further
excluded women who were pregnant at any examination (n =
217). After these exclusions, at baseline, a total of 4162 par-
ticipants (81.4% of 5115) remained for analyses. All participants
provided informed consent at each examination. The study de-
sign and data collection and analyses were approved by the
institutional review boards of the centers involved.
Assessment of diet
The CARDIA diet-history questionnaire, a validated interviewer-
administered quantitative food-frequency questionnaire (FFQ),
was designed to assess habitual eating patterns. The validity and
reproducibility of CARDIA FFQ were described in previous
studies (19, 20). Briefly, dietary information was collected in
1985, 1992, and 2005. Nutrient intake was estimated by using an
adaptively updated nutrient database from the Nutrition Co-
ordinating Center at the University of Minnesota (NCC Nutrient
Database, version 20, October 1991; Nutrition Coordinating Center,
University of Minnesota, Minneapolis). In this study, LCv3PUFA
represented the sum of EPA, docosapentaenoic acid, and DHA.
Previous data suggested that the preparation method, particularly
deep frying, may substantially alter the fatty acid content of fish
(ie, by reducing LCv3PUFA levels and producing trans fatty
acids) (21). Therefore, we categorized fish consumption into 2
groups: nonfried fish and fried fish.
Assessment of asthma
The incidence of asthma was identified if a participant reported
that he or she had asthma diagnosed by a physician and/or reported
the use of any asthma-control medicine (medicine containers were
examined) at any follow-up exam (22). In this study, we could not
define atopic asthma based on available information. However, we
used a self-reported diagnosis of hay fever as an indicator of atopic
history and considered atopic status as a modifier in the analysis.
Assessment of covariates
Standard questionnaires were used to maintain consistency in
the assessment of demographic and behavioral information, in-
cluding age, sex, race, and education level (,13, 13–15, or$16 y)
across all CARDIA examinations. Smoking status was clas-
sified into 3 groups: current, former, or never. Alcohol con-
sumption was measured by using a validated questionnaire and
classified into 4 groups according to the total daily consump-
tion: 0 (never drink), 0.1–9.9, 10–19.9, or $20 mL/d. BMI was
calculated as weight (in kg) divided by height (in m) squared.
Weight and height were directly measured while the partici-
pant stood in light clothes and no shoes. In this study, BMI was
classified into 3 groups: ,25, 25–29.9, or $30 kg/m2 (23).
Physical activity was assessed by using the interview-based,
validated CARDIA physical activity history questionnaire. A
score of 100 exercise units is approximately equivalent to
participation in vigorous activity for 2 to 3 h per week during 6
mo of the year (24). Self-reported diagnosis of hay fever was
used as an indicator of atopic history (25).
Statistical analyses
Participants were divided into quintiles (#0.050, 0.051–0.090,
0.091–0.145, 0.146–0.239, or $0.240 g/d) according to the
distribution of the cumulative average LCv3PUFA intake.
Group comparisons of baseline characteristics were performed
by ANOVA, the Kruskal-Wallis test, or the chi-square test when
appropriate.
Cox proportional hazards regression models were used to
estimate the HRs and 95% CIs by comparing participants in
higher quintiles of LCv3PUFA intake to the lowest quintile.
Each participant contributed follow-up time from the date of the
baseline examination until the date in which asthma was first
identified or first censored or until the end of the follow-up
period. To best represent long-term dietary intake and to reduce
measurement errors, we used cumulative average intakes of
nutrients in the main analyses (26). For example, we related
baseline LCv3PUFA intake to incident asthma identified at
years 2 and 5; average LCv3PUFA intake at baseline and exam
year 7 to new cases occurring at years 7, 10, and 15; and average
LCv3PUFA intake at baseline and years 7 and 20 to new cases
occurring at year 20. For the noncases, we also used average
LCv3PUFA intake from all the 3 visits.
The initial analyses (model 1) were adjusted for age, sex, race,
and study center; model 2 additionally adjusted for education,
smoking status, alcohol consumption, physical activity, BMI, and
total energy intake; and model 3 additionally adjusted for linoleic
acid. Linoleic acid is the primary essential v-6 fatty acid and has
been shown to be proinflammatory (27). The competition for
desaturases and elongases in v-3 and v-6 PUFA metabolism
results in opposite effects on tissue concentration of these v3-
and v-6 PUFA (28). In a supplemental analysis, we assessed the
potential modification of v-6 PUFA intake on the association of
LCv3PUFA intake with incident asthma and the association
between the ratio of LCv3PUFA to v-6 PUFA and incidence of
asthma. The median values in each quintile were used as con-
tinuous variables for trend estimates.
In addition, we evaluated the possible interactions between
LCv3PUFAs and sex, race (African American and white), BMI
(,25 or $25 kg/m2), smoking status (current, former, or never
smoker), atopic history (with or without hay fever) (25), and v-6
PUFA intake (above compared with below median) by adding
corresponding multiplicative interaction terms in the models,
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followed by the likelihood ratio test. All analyses were con-
ducted by using SAS (version 9.2; SAS Institute Inc). P # 0.05
was considered statistically significant.
RESULTS
Baseline characteristics of the study population according to
quintiles of LCv3PUFA intake are shown in Table 1. Compared
with participants in the lowest quintile, those in the highest
quintile were slightly older, were more likely to be males and
African Americans, and had relatively high education levels.
During the 20-y follow-up, 446 incident cases of asthma were
identified. LCv3PUFA intake was inversely associated with
incidence of asthma after adjustment for potential dietary and
nondietary confounders (Table 2). The multivariable-adjusted
HR of asthma reduced monotonically and inversely by quintiles
of LCv3PUFA intake. Participants in the highest quintile of
LCv3PUFA intake had a significantly lower incidence of asthma
(HR: 0.46; 95% CI: 0.33, 0.64; P-trend , 0.01) than did those
who were in the lowest quintile. DHA had a greater inverse
association with incidence of asthma than did EPA (HR with
DHA: 0.30; 95% CI: 0.22, 0.41; P , 0.01; HR with EPA: 0.71;
95% CI: 0.52, 0.97; P = 0.0496). Because of the narrow distri-
bution (the great majority of participants reported no fried fish
consumption), we were not able to examine fried fish consumption
separately. No statistically significant associations were found be-
tween nonfried fish consumption and incidence of asthma after
adjustment for fried fish and other potential confounders.
The observed inverse associations between LCv3PUFA intake
and incidence of asthma were not appreciably modified by
atopic history, sex, race, BMI, or smoking status. However, the
inverse association between LCv3PUFA intake and incidence of
asthma was attenuated by a high intake of v-6 PUFA (see
Supplemental Table 1 under “Supplemental data” in the online
issue). In addition, the ratio of v-3 to v-6 was inversely asso-
ciated with asthma development (see Supplemental Table 2
under “Supplemental data” in the online issue). To test the ro-
bustness of our findings, several sensitivity analyses (data not
shown) were conducted. First, our findings persisted after we
further adjusted for nicotine levels and for other nutrients, in-
cluding folic acids, magnesium, zinc, sodium, and several an-
tioxidants (b-carotene, vitamin A, vitamin C, vitamin D, and
vitamin E). We adjusted for these nutrients because fish is
a good source of vitamins and minerals in addition to being an
excellent source of the marine-derived v-3 fatty acids (29).
Some previous studies have suggested effects of those nutrients
on inflammatory disorders and lung function (30–32). Second,
when we excluded participants with self-reported other allergic
diseases at baseline (n = 6), the results were essentially un-
changed. Third, because the time of events is interval censored,
we used midpoint imputation rather than right-point imputation
in the main analyses (33). The results were robust to these
changes.
DISCUSSION
This longitudinal study showed an inverse association between
intake of LCv3PUFAs and incidence of asthma, independently
of major lifestyle, sociodemographic, and other dietary con-
founders. The observed inverse association was modified by
v-3 PUFA intake, but not appreciably modified by sex, race, BMI,
smoking status, or atopic history.
Data directly relating LCv3PUFAs to asthma are limited. A
cross-sectional study found that plasma LCv3PUFAs were not
TABLE 1
Baseline characteristics of the study population according to quintiles of LCv3PUFA intake: CARDIA study, 1985–20051
Characteristics
Quintile of LCv3PUFA intake
Total (n = 4162) P value21 (n = 877) 2 (n = 800) 3 (n = 822) 4 (n = 829) 5 (n = 834)
LCv3PUFAs (g/d) 0.03 6 0.013 0.07 6 0.01 0.12 6 0.02 0.19 6 0.03 0.41 6 0.28 0.16 6 0.19
EPA (g/d) 0.01 6 0.01 0.03 6 0.01 0.04 6 0.02 0.07 6 0.02 0.17 6 0.14 0.06 6 0.08
DHA (g/d) 0.01 6 0.01 0.03 6 0.01 0.05 6 0.02 0.09 6 0.02 0.19 6 0.14 0.07 6 0.09
DPA (g/d) 0.01 6 0.01 0.01 6 0.01 0.02 6 0.01 0.03 6 0.01 0.05 6 0.03 0.02 6 0.02
Nonfried fish (servings/d) 0.2 6 0.2 0.5 6 0.3 0.8 6 0.5 1.2 6 0.7 2.2 6 1.5 1.0 6 1.1 ,0.01
Age (y) 24.3 6 3.7 24.8 6 3.6 24.9 6 3.7 25.3 6 3.4 25.3 6 3.5 24.9 6 3.6 ,0.01
Male (%) 39.0 42.6 46.8 50.9 55.9 47.0 ,0.01
African American (%) 47.4 46.1 51.0 50.2 57.1 50.4 ,0.01
Education (y) 13.3 6 2.2 13.8 6 2.2 13.8 6 2.2 14.1 6 2.3 14.1 6 2.4 13.8 6 2.3 ,0.01
BMI (kg/m2) 24.2 6 4.8 24.9 6 5.6 24.5 6 5.1 24.2 6 4.8 24.7 6 4.6 24.5 6 5.0 0.052
Current smoker (%) 32.4 30.4 30.3 26.2 29.1 29.7 ,0.01
Physical activity (exercise unit) ,0.01
Median 302 352 354 368 441 364
IQR4 163–502 197–563 192–561 209–575 258–672 198–577
Alcohol intake (mL/d) ,0.01
Median 2.4 2.7 4.8 5.2 7.5 4.8
IQR4 0.0–13.6 0.0–12.6 0.0–14.3 0.0–17.0 0.0–21.2 0.0–15.0
LA (g/d) 15.6 6 8.4 17.6 6 8.3 19.5 6 8.9 20.9 6 9.9 24.7 6 11.7 19.7 6 10.0 ,0.01
Total energy intake (kcal/d) 2416.8 6 1054.9 2503.4 6 987.0 2706.4 6 1081.9 2836.6 6 1089.4 3295.4 6 1270.1 2750.3 6 1143.7 ,0.01
Atopic history (%) 28.1 26.8 27.5 33.5 30.6 29.3 0.02
1CARDIA, Coronary Artery Risk Development in Young Adults; DPA, docosapentaenoic acid; LA, linoleic acid; LCv3PUFA, long-chain omega-3 PUFA.
2Reflects differences across the quintiles of LCv3PUFA intake (ANOVA, Kruskal-Wallis test, or chi-square test as appropriate).
3Mean 6 SD (all such values).
4Reflects 25th275th percentiles.
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associated with prevalence of asthma among young adults (34).
Dietary fish intake had a beneficial effect on wheezing; however,
adjustment for vitamin C made this association statistically
nonsignificant (11). Moreover, no significant association was
found between childhood fish intake and adult-onset asthma
(35). Similarly, 3 prospective studies that examined adult intake
of LCv3PUFAs and incident asthma (13–15) found no signifi-
cant association. Of note, in these studies performed in middle-
aged or older men and/or women [women 35–65 y and men
40–65 y (15) of age; women 34–68 y (13) or men older than
65 y (14)], asthma may be difficult to be differentiated from
chronic obstructive pulmonary diseases (36), particularly, when
the prevalence of smoking is high (74%) (14). In addition, some
evidence suggests that cigarette smoking is a major risk factor
for asthma (37). Residual confounding from this risk factor may
attenuate or mask any association of asthma with LCv3PUFAs.
The inconsistent results between our study and the previous
studies may not be explained by the sex and atopic history of
participants because we found that these 2 factors did not ma-
terially modify the observed associations.
Our findings of the potential beneficial effect of LCv3PUFA
intake on asthma development are biologically plausible. Evi-
dence from both experimental and observational studies sug-
gested that LCv3PUFAs are antiinflammatory (3, 4, 27). A
possible mechanism for the effect of LCv3PUFAs on in-
flammation is that LCv3PUFAs inhibit arachidonic acid (AA)
metabolism competitively via enzymatic pathways (38) and sup-
press the production of active inflammatory eicosanoid mediators
from AA (29, 39, 40). This effect was further investigated recently
(30). Whereas most of the products of AA are endowed with
TABLE 2
Multivariable-adjusted HRs (95% CIs) of incidence of asthma by cumulative intakes (quintiles) of LCv3PUFAs, EPA, DHA, and nonfried fish: CARDIA
study, 1985–2005 (n = 4162)1
Dietary variable
Quintile of LCv3PUFA intake
P-trend21 (lowest) 2 3 4 5 (highest)
LCv3PUFAs (g/d)3 #0.050 0.051–0.090 0.091–0.145 0.146–0.239 $0.24
Mean 6 SD 0.03 6 0.01 0.07 6 0.01 0.12 6 0.02 0.19 6 0.03 0.41 6 0.28
Median 0.03 0.07 0.12 0.19 0.34
No. of incident asthma cases 126 92 81 78 69
Person-years at risk 12,379 12,816 13,920 14,346 14,367
HR model 14 1 0.71 (0.54, 0.93) 0.59 (0.45, 0.78) 0.56 (0.42, 0.74) 0.50 (0.37, 0.67) ,0.01
HR model 25 1 0.70 (0.53, 0.91) 0.56 (0.42, 0.74) 0.52 (0.39, 0.70) 0.43 (0.31, 0.59) ,0.01
HR model 36 1 0.73 (0.55, 0.96) 0.60 (0.45, 0.80) 0.56 (0.42, 0.76) 0.46 (0.33, 0.64) ,0.01
EPA (g/d) ,0.02 0.02–0.03 0.03–0.06 0.06–0.09 .0.10
Mean 6 SD 0.01 6 0.01 0.02 6 0.00 0.04 6 0.01 0.07 6 0.01 0.17 6 0.13
Median 0.01 0.02 0.04 0.07 0.14
No. of incident asthma cases 104 102 78 80 82
Person-years at risk 12,006 13,578 14,670 13,478 14,096
HR model 14 1 0.89 (0.67, 1.17) 0.63 (0.47, 0.85) 0.71 (0.53, 0.96) 0.72 (0.53, 0.97) 0.06
HR model 25 1 0.89 (0.67, 1.17) 0.62 (0.46, 0.84) 0.69 (0.51, 0.93) 0.66 (0.48, 0.89) 0.02
HR model 36 1 0.92 (0.70, 1.22) 0.66 (0.49, 0.90) 0.74 (0.54, 1.00) 0.71 (0.52, 0.97) 0.05
DHA (g/d) ,0.02 0.02–0.04 0.04–0.07 0.07–0.11 .0.11
Mean 6 SD 0.01 6 0.01 0.03 6 0.01 0.05 6 0.01 0.09 6 0.01 0.20 6 0.14
Median 0.01 0.03 0.05 0.09 0.16
No. of incident asthma cases 129 89 94 69 65
Person-years at risk 8844 13,973 15,751 14,354 14,906
HR model 14 1 0.45 (0.34, 0.59) 0.43 (0.33, 0.56) 0.34 (0.26, 0.46) 0.32 (0.23, 0.43) ,0.01
HR model 25 1 0.45 (0.34, 0.59) 0.42 (0.32, 0.54) 0.33 (0.24, 0.45) 0.28 (0.21, 0.39) ,0.01
HR model 36 1 0.46 (0.35, 0.61) 0.44 (0.33, 0.58) 0.35 (0.26, 0.47) 0.30 (0.22, 0.41) ,0.01
Nonfried fish (servings/d)7 ,0.24 0.24–0.51 0.52–0.86 0.87–1.46 .1.46
Mean 6 SD 0.10 6 0.08 0.37 6 0.08 0.68 6 0.10 1.13 6 0.17 2.52 6 1.44
Median 0.10 0.37 0.67 1.11 2.07
No. of incident asthma cases 102 93 82 83 86
Person-years at risk 12,434 13,644 14,009 14,110 13,631
HR model 14 1 0.88 (0.66, 1.16) 0.77 (0.57, 1.03) 0.78 (0.58, 1.04) 0.88 (0.65, 1.18) 0.51
HR model 25 1 0.89 (0.67, 1.19) 0.77 (0.57, 1.03) 0.75 (0.56, 1.02) 0.83 (0.61, 1.12) 0.27
HR model 36 1 0.92 (0.69, 1.22) 0.81 (0.60, 1.10) 0.80 (0.59, 1.08) 0.89 (0.65, 1.22) 0.52
1All models were constructed by the Cox proportional hazards model. CARDIA, Coronary Artery Risk Development in Young Adults; DPA, docosa-
pentaenoic acid; LCv3PUFAs, long-chain omega-3 PUFAs.
2Variables using medians in each quintile were created for the trend test.
3Defined as EPA + DPA + DHA.
4Model 1: adjusted for age (continuous), sex, race (African American or white), and study center.
5Model 2: additionally adjusted for education (,13, 13–15, or $16 y), smoking status (never, former, or current), alcohol consumption (0, 0.1–9.9,
10–19.9, or $20 mL/d), physical activity (quintile), BMI (in kg/m2; ,25, 25–29.9, or $30), and total energy intake (quintile).
6Model 3: additionally adjusted for dietary intake (quintiles) of linoleic acid.
7 Fried fish intake (yes or no) was adjusted only in models when studying nonfried fish.
184 LI ET AL
proinflammatory activity, some are antiinflammatory and others
have contrasting activities (eg, prostaglandin E2 has both pro-
and antiinflammatory actions). Recently, lipid mediators derived
from EPA and DHA have been identified as playing a role in
inflammation (41).
Our finding that DHA was superior to EPA with respect to
asthma prevention is compatible with previous findings. In vitro
studies have shown that DHA was more potent than EPA at
decreasing the expression of proinflammatory cytokines, cell-
adhesion molecules, and monotype adhesion to endothelial cells
(42). Moreover, studies that measured serum or plasma fatty acids
as biomarkers for dietary intake showed that a high concentration
of DHA but not EPA in serum phospholipids (43) and plasma (44)
may have a protective effect on airway hyperresponsiveness (44),
lung function (43), and other chronic inflammatory conditions of
the lung (44).
Studies suggest that v-6 PUFAs may compete with v-3 PUFAs
for key enzymes in the metabolisms. Consistently, we found that
the inverse associations between LCv3PUFA intake and inci-
dence of asthma were substantially attenuated by high intakes of
v-6 PUFA intake.
In this study, LCv3PUFAs, but not nonfried fish consumption,
were significantly associated with reduced incidence of asthma.
Fish is a package of nutrients and contaminants, whereas
LCv3PUFAs are considered to be the key nutrients responsible
for its benefits. The integrative effects of fish consumption may
reflect the interactions of LCv3PUFAs with other nutrients and
contaminants in fish. Our finding of no association might be
explained by contaminants in fish, such as mercury (45, 46) and
polychlorinated biphenyls (PCBs) (47), and/or added sodium
(48, 49), which could have substantially attenuated or masked
a potential beneficial effect of nonfried fish on asthma. The types
of fish meal are important with respect to the investigation of
contaminants in fish (50). Mercury has been found to be a major
factor in allergic/immune reactive conditions, including asthma
(45, 46). PCBs have been associated with an increased risk of
asthma in Flemish children (47), although the health effects of
chronic low-level PCB exposure were less well studied. In ad-
dition, intervention studies found an increase in airway re-
sponsiveness when dietary sodium was increased (48, 49). Thus,
the associations of fish and LCv3PUFAs with health endpoints
may not be necessarily consistent.
Our study had many strengths that support the validity of our
findings. The main strengths of this study were the prospective
design, a relatively large sample size and diverse population, and
the high follow-up rates, which reduced the concern that the
results were affected by differential follow-up rates. In addition,
we used a validated FFQ (19) and cumulative average dietary
consumption information from 3 time points that should reduce
random measurement error and provide a better estimate of
habitual intake than a single estimate (26).
A few limitations in this study should be considered. First, our
study was observational by design; thus, we could not rule out
residual confounding, nor could we draw conclusive statements
about the preventive effect of LCv3PUFA consumption on the
development of asthma. Although we controlled for many poten-
tial confounders in the analyses, the possibility of unmeasured
confounders cannot be excluded. Second, information on fish-oil
supplement use is not available in CARDIA. However, the
CARDIA baseline diet was assessed in 1985–1986, when few
people were using fish-oil supplements. When we used only the
baseline diet in the analysis, the results remained. Thus, our
results should not be substantially biased by fish-oil supplement
use. Third, the definition of asthma was mainly based on a self-
reported doctor diagnosis of asthma and could not distinguish
atopic asthma from other types, which may have resulted in
some misclassification of asthma status and time of onset;
however, it is unlikely that a misclassification other than a ran-
dom or nondifferential one occurred. Also, when we further
adjusted atopic status indicated by hay fever, the results re-
mained. In addition, the measurement error of dietary data are
inevitable, but the measurements of LCv3PUFA intake and fish
consumption should enable us to rank the participants and es-
timate the RRs. Also, the measurement error has been largely
reduced by using cumulative average intakes.
In conclusion, the results of this prospective study provide
evidence that LCv3PUFA intake is inversely associated with in-
cident asthma. Further studies, particularly randomized placebo-
controlled clinical trials are needed to establish causal inference.
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